New scan agent shows promise for prostate cancer detection
Diagnosis
Completed
This study tested a new imaging agent called 68Ga-NTA-476 for PET scans in 10 men with prostate cancer. The goal was to see how well it finds tumors compared to the standard scan, and to check for side effects. This was the first time this agent was used in humans, so safety and …
Phase: EARLY_PHASE1 • Sponsor: Melbourne Theranostic Innovation Centre • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC